Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy

By Merwe Lize   Cloete Ruben   Revera Miriam   Heradien Marshall   Goosen Althea   Corfield Valerie   Brink Paul   Moolman-Smook Johanna  

Human Genetics, Vol. 124, Iss. 1, 2008-08 ,pp. : 57-61

Springer Publishing Company

Access to resources Recommend Favorite

Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency

By Jaksch Michaela  

Human Molecular Genetics, Vol. 9, Iss. 5, 2000-03 ,pp. : 795-801

Oxford University Press

Access to resources Recommend Favorite

A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy

By Meurs Kathryn M.   Sanchez Ximena   David Ryan M.   Bowles Neil E.   Towbin Jeffrey A.   Reiser Peter J.   Kittleson Judith A.   Munro Marcia J.   Dryburgh Keith   MacDonald Kristin A.   Kittleson Mark D.  

Human Molecular Genetics, Vol. 14, Iss. 23, 2005-12 ,pp. : 3587-3593

Oxford University Press

Access to resources Recommend Favorite

Co‐occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11

By  

American Journal Of Medical Genetics Part A, Vol. 167, Iss. 12, 2015-12 ,pp. : 3144-3147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His

By  

American Journal Of Medical Genetics Part A, Vol. 155, Iss. 10, 2011-10 ,pp. : 2529-2533

John Wiley & Sons Inc

Access to resources Recommend Favorite